Results 1 to 10 of about 364 (94)

Safety and Efficacy of Aveir Leadless Pacemaker in Chinese Patients [PDF]

open access: yesAnnals of Noninvasive Electrocardiology
Background Aveir, as a newly approved leadless pacemaker (LP), has been increasingly adopted in clinical practice. However, its application in the Chinese population remains limited.
Qiang Xie, Ziguan Zhang, Wuyang Zheng
exaly   +3 more sources

Leadless Versus Transvenous Single‐Chamber Ventricular Pacemakers: Real‐World Evidence From Aveir VR Coverage With Evidence Development Study [PDF]

open access: yesJournal of the American Heart Association
Background Aveir VR, a helix‐fixation leadless pacemaker (LP), was US Food and Drug Administration (FDA)‐approved in 2022. The performance of this novel LP has not been evaluated against transvenous single chamber ventricular pacemakers (TV‐VVI) in a ...
Anne Kroman
exaly   +4 more sources

Leadless Helix-fixation Pacemakers in Solid Organ Transplant Recipients: A Multisite Experience [PDF]

open access: yesTransplantation Direct
Background. Solid organ transplant recipients (SOTRs) are at heightened risk for cardiovascular implantable electronic device-related complications, particularly infection, because of chronic immunosuppression and comorbidities.
Amal Youssef, MD   +6 more
doaj   +2 more sources

Successful snare retrieval of a dislodged AVEIR leadless pacemaker from right pulmonary artery: a case report [PDF]

open access: yesJournal of Cardiothoracic Surgery
Background Leadless pacemakers (LPs) are safer and more effective alternatives to traditional transvenous pacemakers, but LP detachment and displacement are serious complications.
Xuelian Song   +4 more
doaj   +2 more sources

Computational analysis of intracardiac collision risk and optimal site for right ventricular leadless left bundle branch area pacing: A simulation study [PDF]

open access: yesHeart Rhythm O2
Background: Conduction system pacing with leadless left bundle branch area pacing (LBBAP) is a promising application of leadless pacemakers (L-PMs). However, the mechanical impact of the L-PM on intracardiac structures may worsen tricuspid regurgitation ...
Angela W.C. Lee, PhD   +8 more
doaj   +2 more sources

Case Report: Aveir implantation in an 8.7-year-old, 25-kg pediatric patient with mitochondrial disease via internal jugular vein

open access: yesFrontiers in Cardiovascular Medicine
IntroductionMitochondrial disorders frequently precipitate progressive conduction system degeneration, with complete heart block representing a critical therapeutic challenge in pediatric populations, which ultimately requires permanent pacemaker ...
Tiewei Lu
exaly   +3 more sources

Retrievable dual-chamber leadless pacemaker implant (Aveir DR) in an adult patient with congenital heart disease

open access: yesIndian Pacing and Electrophysiology Journal
Leadless pacemakers have demonstrated potential as a transvenous pacing option in Adult Congenital Heart Disease patients. Aveir™ single-chamber (VR) leadless pacemakers have demonstrated safety in patients without congenital heart disease in a dual ...
Daniel Cortez
exaly   +3 more sources

Atrial placement of Aveir-VR leadless pacemaker in a patient with complex cardiac anatomy

open access: yesIndian Pacing and Electrophysiology Journal
Leadless pacemakers have provided new treatment modalities that can be especially useful in patients with complex cardiac anatomy and contraindications toward other pacemaker approaches.
Daniel Cortez, Javier Aguayo
exaly   +3 more sources

Intracardiac Echocardiography–Guided Implantation of Aveir VR Leadless Pacemaker [PDF]

open access: yesJournal of Arrhythmia
Kazuhisa Matsumoto   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy